India’s cancer diagnostics market is expected to reach USD 14.4 billion by 2034, with a compound annual growth rate of 7.06%. Molecular diagnostics, next-generation sequencing, liquid biopsies, and AI-powered diagnostic tools are driving market growth, while the rising burden of cancer, increased awareness of screening, and population aging continue to expand diagnostic demand.
Source:Stay Updated With Medical Buyer · Read Original
Leave a Reply